AVP-13358

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAVP-13358
Drug Alias NameAVP-13358
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvanir Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvanir Pharma
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A